Drugs / Pyritinol
Pyritinol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02374567 | Jan 2015 → Jun 2017 | anxiety disorder, dementia, depressive disorder, schizophrenia +1 | Hannover Medical School | Terminated | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pyritinol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02374567 ↗ |
| Known as | NSC-759229 | ChEMBL registry synonym — accepted as the source's own label CHEMBL488093 ↗ |
| Known as | Piritinol | ChEMBL registry synonym — accepted as the source's own label CHEMBL488093 ↗ |
| Known as | Pyrithioxin | ChEMBL registry synonym — accepted as the source's own label CHEMBL488093 ↗ |
| Known as | Pyrithioxine | ChEMBL registry synonym — accepted as the source's own label CHEMBL488093 ↗ |
| Modality | Small molecule | — CHEMBL488093 ↗ |